Form 4: Abbott Laboratories Executive Lisa D. Earnhardt Reports Stock Option Exercise and Sale

Lisa D. Earnhardt, an Executive Vice President and Group President at Abbott Laboratories, reported exercising stock options and selling shares on March 6 and 7, 2025.

Summary

• On March 6, 2025, Lisa D. Earnhardt exercised options to acquire 91,167 Abbott Laboratories common shares at a price of $80.98 per share and sold the same amount at $133.82 per share.
• On March 7, 2025, she exercised options to acquire 200 Abbott Laboratories common shares at a price of $80.98 per share and sold the same amount at $136.645 per share.
• Following these transactions, Earnhardt directly owns 71,928 common shares of Abbott Laboratories.
• She also directly owns 200 options to buy Abbott Laboratories common shares at a price of $80.98.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently suggest positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives who receive stock options as part of their compensation. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely negligible given the overall size of the company.

Key Dates